Afam Capital Inc. Has $1.64 Million Position in Medtronic plc. (MDT)

Afam Capital Inc. increased its holdings in Medtronic plc. (NYSE:MDT) by 7.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,123 shares of the medical technology company’s stock after purchasing an additional 1,396 shares during the quarter. Afam Capital Inc.’s holdings in Medtronic were worth $1,643,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also modified their holdings of the stock. BDO Wealth Advisors LLC bought a new stake in Medtronic in the 2nd quarter worth $103,000. Motco grew its holdings in Medtronic by 8.7% in the 2nd quarter. Motco now owns 1,239 shares of the medical technology company’s stock worth $110,000 after acquiring an additional 99 shares during the last quarter. Quadrant Capital Group LLC grew its holdings in Medtronic by 21.5% in the 2nd quarter. Quadrant Capital Group LLC now owns 1,639 shares of the medical technology company’s stock worth $114,000 after acquiring an additional 290 shares during the last quarter. Blue Chip Partners Inc. bought a new stake in Medtronic in the 3rd quarter worth $118,000. Finally, Kistler Tiffany Companies LLC grew its holdings in Medtronic by 7.8% in the 2nd quarter. Kistler Tiffany Companies LLC now owns 1,642 shares of the medical technology company’s stock worth $146,000 after acquiring an additional 119 shares during the last quarter. Institutional investors own 81.72% of the company’s stock.

Shares of Medtronic plc. (MDT) opened at $85.73 on Friday. Medtronic plc. has a 52 week low of $73.59 and a 52 week high of $89.72. The company has a debt-to-equity ratio of 0.50, a quick ratio of 2.05 and a current ratio of 2.40. The company has a market cap of $115,710.00, a PE ratio of 23.55, a P/E/G ratio of 2.35 and a beta of 0.99.

Medtronic (NYSE:MDT) last posted its quarterly earnings data on Tuesday, November 21st. The medical technology company reported $1.07 EPS for the quarter, topping the consensus estimate of $0.99 by $0.08. Medtronic had a net margin of 16.93% and a return on equity of 12.63%. The business had revenue of $7.05 billion for the quarter, compared to analyst estimates of $7.05 billion. During the same quarter in the previous year, the firm posted $1.12 earnings per share. Medtronic’s quarterly revenue was down 4.0% on a year-over-year basis. analysts expect that Medtronic plc. will post 4.77 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 19th. Investors of record on Friday, December 29th will be paid a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a yield of 2.15%. The ex-dividend date of this dividend is Thursday, December 28th. Medtronic’s payout ratio is currently 50.55%.

MDT has been the topic of a number of recent analyst reports. Jefferies Group reissued a “buy” rating and issued a $96.00 price target on shares of Medtronic in a report on Thursday, September 28th. SunTrust Banks reaffirmed a “buy” rating and set a $96.00 target price on shares of Medtronic in a research note on Monday, October 2nd. Wells Fargo & Co lowered shares of Medtronic from an “outperform” rating to a “market perform” rating and cut their target price for the company from $93.00 to $83.00 in a research note on Monday, October 9th. Royal Bank of Canada cut their target price on shares of Medtronic from $90.00 to $85.00 and set an “outperform” rating on the stock in a research note on Monday, October 9th. Finally, Stifel Nicolaus cut their target price on shares of Medtronic from $91.00 to $83.00 and set a “hold” rating on the stock in a research note on Monday, October 9th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and fifteen have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $89.65.

In related news, EVP Bryan C. Hanson sold 16,000 shares of the business’s stock in a transaction dated Monday, October 16th. The shares were sold at an average price of $78.03, for a total transaction of $1,248,480.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Richard Kuntz sold 78,526 shares of the business’s stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $86.21, for a total transaction of $6,769,726.46. Following the sale, the vice president now directly owns 149,761 shares in the company, valued at approximately $12,910,895.81. The disclosure for this sale can be found here. Insiders have sold 152,684 shares of company stock worth $12,831,076 in the last three months. 0.31% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION WARNING: “Afam Capital Inc. Has $1.64 Million Position in Medtronic plc. (MDT)” was posted by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.com-unik.info/2018/01/12/afam-capital-inc-has-1-64-million-position-in-medtronic-plc-mdt.html.

Medtronic Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc. (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit